Use of subcutaneous DDAVP in infants with central diabetes insipidus

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 7, 2006, Pages 919-925

  Blanco, Ernesto J ^a   Lane, Andrew H ^a   Aijaz, Naghma ^a   Blumberg, Denise ^b   Wilson, Thomas A ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b NASSAU UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Central diabetes insipidus; Infancy; Intranasal DDAVP; Intranasal lysine vasopressin; Subcutaneous DDAVP

Indexed keywords

DESMOPRESSIN; LYPRESSIN; SODIUM;

ARTICLE; CLINICAL ARTICLE; DIABETES INSIPIDUS; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPONATREMIA; INFANT; INFANT DISEASE; MALE; MEDICAL RECORD REVIEW; SEIZURE; SODIUM BLOOD LEVEL; TREATMENT OUTCOME;

EID: 33748444345     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.7.919     Document Type: Article

References (9)

1. Bode H, Crawford J, Danon M. Disorders of antidiuretic hormone homeostasis: diabetes insipidus and SIADH. In: Lifshitz F, ed. Pediatric Endocrinology, 4th Ed. New York: Marcel Dekker, Inc., 1996; 735-743.
2. Muglia L, Majzoub J. Disorders of the posterior pituitary. In: Sperling M, ed. Pediatric Endocrinology, 2nd Ed. Philadelphia, PA: Saunders, 2002; 289-322.
3. Crigler JF Jr. Commentary: On the use of pitressin in infants with neurogenic diabetes insipidus. J Pediatr 1976; 88: 295-296.
4. Seow WK, Thomsett MJ. Dental fluorosis as a complication of hereditary diabetes insipidus: studies of six affected patients. Pediatr Dent 1994; 16: 128-132.
5. Uribarri J, Kaskas M. Hereditary nephrogenic diabetes insipidus and bilateral non-obstructive hydronephrosis. Nephron 1993; 65: 346-349.
6. Rizzo V, Albanese A, Stanhope R. Morbidity and mortality associated with vasopressin replacement therapy in children. J Pediatr Endocrinol Metab 2001; 14: 861-867.
7. Hillman DA, Neyzi O, Porter P, Cushman A, Talbot NB. Renal (vasopressin resistant) diabetes insipidus: definition of the effects of a homeostatic limitation in capacity to conserve water on the physical, intellectual and emotional development of a child. Pediatrics 1958; 21: 430-435.
8. Westgren U, Wittstrom C, Harris AS. Oral desmopressin in central diabetes insipidus. Arch Dis Child 1986; 61: 247-250.
9. Green RP, Landt M. Home sodium monitoring in patients with diabetes insipidus. J Pediatr 2002; 141: 618-624.